Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 8, 2013, Pages

  Papin, James F ^a   Wolf, Roman F ^a   Kosanke, Stanley D ^a   Jenkins, Justin D ^a   Moore, Sara N ^a   Anderson, Michael P ^b   Welliver, Robert C ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Animal models; Baboon model; Bronchiolitis; Interstitial pneumonia; Respiratory syncytial virus vaccine

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; VIRUS ANTIGEN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; AUTOPSY; BABOON; BREATHING RATE; BRONCHIOLE; CLINICAL OBSERVATION; HISTOPATHOLOGY; INFLAMMATORY CELL; INOCULATION; LEUKOCYTE COUNT; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TACHYPNEA; VACCINATION; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; ANIMAL DISEASE; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; HUMAN; IMMUNOLOGY; INFANT; LUNG; MONKEY DISEASE; PAPIO ANUBIS; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SPECIES DIFFERENCE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; HUMANS; INFANT; LUNG; MONKEY DISEASES; PAPIO ANUBIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; SPECIES SPECIFICITY; VIRUS REPLICATION;

MLCS; MLOWN;

EID: 84878642826     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00173.2012     Document Type: Article

References (37)

1. Aberle JH, Aberle SW, Rebhandl W, Pracher E, Kundi M, Popow-Kraupp T. Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants. Clin Exp Immunol 137: 146-150, 2004.
2. Angen Ø, Thomsen J, Larsen LE, Larsen J, Kokotovic B, Heegaard PMH, Enemark JMD. Respiratory disease in calves: microbiological investigations on trans-tracheally aspirated bronchoalveolar fluid and acute phase protein response. Vet Microbiol 137: 165-171, 2009.
3. Antonis AFG, de Jong MC, van der Poel WHM, van der Most RG, Stockhofe-Zurwieden N, Kimman T, Schrijver RS. Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence. J Gen Virol 91: 2497-2506, 2010.
4. Belknap EB, Ciszewski DK, Baker JC. Experimental respiratory syncytial virus infection in calves and lambs. J Vet Diagnostic Invest 7: 285-298, 1995.
5. Belshe RB, Richardson LS, London WT, Sly DL, Lorfeld JH, Camargo E, Prevar DA, Chanock RM. Experimental respiratory syncytial virus infection of four species of primates. J Med Virol 1: 157-162, 1977.
6. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, Marchal JL, Dass SB, Reiss TF, Knorr BA. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Resp Crit Care 178: 854-860, 2008.
7. Bont L, Heijnen CJ, Kavelaars A, Aalderen WMCv, Brus F, Draaisma JMT, Pekelharing-Berghuis M, Diemen-Steenvoorde RAAMv, Kimpen JLL. Local interferon-levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 184: 355-358, 2001.
8. Chen FC, Li WH. Genomic divergences between humans and other hominoids and the effective population size of the common ancestor of humans and chimpanzees. Am J Hum Genet 68: 444-456, 2001.
9. Cooper GM, Brudno M, Program NCS, Green ED, Batzoglou S, Sidow A. Quantitative estimates of sequence divergence for comparative analyses of mammalian genomes. Genome Res 13: 813-820, 2003.
10. Crowe JE Jr, Murphy BR, Chanock RM, Williamson RA, Barbas CF 3rd, Burton DR. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci USA 91: 1386-1390, 1994.
11. de Swart RL, Kuiken T, Timmerman HH, Amerongen Gv, van den Hoogen BG, Vos HW, Neijens HJ, Andeweg AC, Osterhaus ADME. Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J Virol 76: 11561-11569, 2002.
12. Farah OR, Li D, McIntyre BAS, Pan J, Belik J. Airway epithelialderived facror relaxes pulmonary vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 296: L115-L120, 2009.
13. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. Macrophage inflammatory protein-1α (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 184: 393-399, 2001.
14. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88: 1026-1033, 1991.
15. Heidema J, Lukens MV, van Maren WWC, van Dijk MEA, Otten HG, van Aught AJ, van der Werff DBM, van Gestel SJP, Semple MG, Smyth RL, Kimpen van Bleek GM JLL. CD8T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol 179: 8410-8417, 2007.
16. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20: 108-119, 2006.
17. Kakuk TJ, Soike K, Brideau RJ, Zaya RM, Cole SL, Zhang JY, Roberts ED, Wells PA, Wathen MW. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated rsv vaccine but not a recombinant FG subunit vaccine. J Infect Dis 167: 553-561, 1993.
18. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89: 422-434, 1969.
19. Lapin CD, Hiatt PW, Langston C, Mason E, Piedra PT. A lamb model for human respiratory syncytial virus infection. Pediatr Pulmonol 15: 151-156, 1993.
20. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 21: 629-632, 2002.
21. Malley R, DeVincenzo J, Ramilo O, Dennehy PH, Meissner HC, Gruber WC, Sanchez PJ, Jafri H, Balsley J, Carlin D, Buckingham S, Vernacchio L, Ambrosino DM. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 178: 1555-1561, 1998.
22. Murthy KSM, Welliver R, Rice KS, Carey KD. Maternal immunization with respiratory syncytial virus vaccine protects infants from viral infection. In: RSV After 45 Years. Segovia, Spain: 2001, p. 69.
23. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EAF, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555, 2010.
24. Olivier A, Gallup J, de Macedo MM, Varga SM, Ackermann M. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int J Exp Pathol 90: 431-438, 2009.
25. Ponnuraj EM, Hayward AR, Raj A, Wilson H, Simoes EAF. Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J Gen Virol 82: 2663-2674, 2001.
26. Prince GA, Suffin SC, Prevar DA, Camargo E, Sly DL, London WT, Chanock RM. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wildtype virus and two temperature-sensitive mutants. Infect Immun 26: 1009-1013, 1979.
27. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J 23: 990-994, 2004.
28. Reed JL, Brewah YA, Delaney T, Welliver TP, Burwell T, Benjamin E, Kuta E, Kozhich A, McKinney L, Suzich J, Kiener PA, Avendano L, Velozo L, Humbles A, Welliver Sr RC, Coyle AJ. Macrophage impairment underlies airways occlusion in primary respiratory syncytial virus bronchiolitis. J Infect Dis 198: 1783-1793, 2008.
29. Richardson LS, Belshe RB, Sly DL, London WT, Prevar DA, Camargo E, Chanock RM. Experimental respiratory syncytial virus pneumonia in cebus monkeys. J Med Virol 2: 45-59, 1978.
30. Sow FB, Gallup JM, Olivier A, Krishnan S, Patera AC, Suzich J, Ackermann MR. Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lungdraining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol Physiol 300: L12-L24, 2011.
31. Spina D. Epithelium smooth muscle regulation and interactions. Am J Respir Crit Care Med 158: S141-S145, 1998.
32. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541-545, 1999.
33. Tristram DA, Welliver RC, Hogerman DA, Hildreth SW, Paradiso P. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. Vaccine 12: 551-556, 1994.
34. Viuff B, Uttenthal Å, Tegtmeier C, Alexandersen S. Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridization. Vet Pathol Online 33: 383-390, 1996.
35. Welliver RC, Kaul TN, Putnam PI, Sun M, Riddlesberger K, Ogra PL. The antibody response to primary and secondary infection with respiratory syncytial virus infection; kinetics of class-specific responses. J Pediatr 96: 808-813, 1980.
36. Welliver RC. Pharmacotherapy of respiratory syncytial virus infection. Curr Opin Pharmacol 10: 289-293, 2010.
37. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126-1136, 2007.